White blood cell count and clinical outcomes after intracerebral hemorrhage: The INTERACT2 trial
详细信息 查看全文
- 作者：Sungwook Yua ; b ; Hisatomi Arimab ; Emma Heeleyb ; Candice Delcourtb ; Martin Krausec ; Bin Pengd ; Jie Yangb ; e ; Guojun Wub ; f ; Xiaoying Chenb ; John Chalmersb ; Craig S. Andersonb ; canderson@georgeinstitute.org.au" class="auth_mail" title="E-mail the corresponding author ; on behalf of the INTERACT2 Investigators1
- 关键词：Clinical trial ; Inflammation ; INTERACT2 ; Intracerebral hemorrhage ; White blood cell ; Outcomes
- 刊名：Journal of the Neurological Sciences
- 出版年：2016
- 出版时间：15 February 2016
- 年：2016
- 卷：361
- 期：Complete
- 页码：112-116
- 全文大小：375 K
文摘
- •
Higher WBC count is associated with risks of death or major disability at 90 days.
- •
Early increase of WBC count is not an independent predictor for short-term outcome.
- •
Further studies on the clinical value of increased WBC count are needed.